MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Omega Diagnostics welcomes £374m value estimate for Covid contract

StockMarketWire.com

Disease test-kit supplier Omega Diagnostics welcomed a government estimate of £374 million for the value of a contract for supplying Covid-19 tests.

Omega noted that the number represented a maximum potential value of the contract.

Care, it said, should be taken not to use the number as an estimate or forecast of the actual likely value of purchase orders to be received by the company.

'Although the disclosed contract value for our agreement with the UK government is only an estimate of what the total value could be worth, it is very encouraging, and is an indication of the substantial impact on Omega's future performance that such a level of utilisation of our lateral flow test production capacity might have,' chief executive Colin King said.

'We look forward to receiving notification of which test will be produced under this arrangement and we will update shareholders as these tests move towards production and purchase orders are received.'





Story provided by StockMarketWire.com